老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

57.99
+2.274.07%
盘后：58.010.0200+0.03%19:59 EDT
成交量：180.15万
成交额：1.05亿
市值：55.66亿
市盈率：-8.96
高：59.16
开：57.35
低：57.05
收：55.72
52周最高：78.48
52周最低：33.03
股本：9,598.53万
流通股本：9,053.30万
量比：1.06
换手率：1.99%
股息：- -
股息率：- -
每股收益(TTM):-6.4700
每股收益(LYR):-6.4700
净资产收益率：-30.18%
总资产收益率：-15.76%
市净率：2.90
市盈率(LYR):-8.96

数据加载中...

总览公司新闻资讯公告
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/29

重要事件披露

Current report, item 5.02
2020/01/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

重要事件披露

Current report, items 1.02, 5.02, and 9.01
2019/12/16

重要事件披露

Current report, items 1.01, 1.02, and 2.01
2019/11/26

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/22

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/19

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/10/28

重要事件披露

Current report, items 2.02 and 9.01
2019/10/28

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/30

重要事件披露

Current report, items 1.01 and 9.01
2019/08/05

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/29

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/07/29

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/07/29

重要事件披露

Current report, items 2.02 and 9.01
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/28

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多